DOCSLIB.ORG

Abstract Book

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstract Book Abstract book WELCOME Dear participants, welcome to the 2010 International PhD Students Cancer Conference here at the IFOM-IEO Campus in Milan! We have tried to organize this conference at our best, hoping it will be an excellent opportunity to discuss about science, to meet new and interesting people and to broad our knowledge. We are very glad to host such an international meeting, with students coming from institutes all across Europe; moreover, this year we are very pleased to host students from the National Centre for Biological Sciences, Bangalore, India. We do hope you will find this conference really exciting and that you will have a great time here in Milan! Thank you all for coming!! The Organizers FOR ORGANIZATION REASONS, YOU ARE KINDLY REQUESTED TO ALWAYS WEAR/SHOW THE CONFERENCE BADGE! THANK YOU VERY MUCH FOR YOUR COLLABORATION! Federica Castellucci: federica.castellucci@ifom-ieo-campus.it Francesca Milanesi: francesca.milanesi@ifom-ieo-campus.it Gianmaria Sarra Ferraris: gianmaria.sarraferraris@ifom-ieo-campus.it Chiara Segrè: chiara.segre@ifom-ieo-campus.it Gianluca Varetti: gianluca.varetti@ifom-ieo-campus.it International PhD Student Cancer Conference International PhD Student Cancer Conference 19th – 21st May 2010 IFOM-IEO Campus, Milan, Italy This is the fourth annual conference that is hosted and organized by students from the European School of Molecular Medicine (SEMM). The Conference will cover many topics related to cancer, from basic biology to clinical aspects of the disease. All attendees will present their research, by either giving a talk or presenting a poster. This conference is an opportunity to introduce PhD students to top cancer research institutes across Europe. International PhD Student Cancer Conference ORGANIZATION SEMM PhD student conference organizing committee Federica Castellucci Francesca Milanesi Gian Maria Sarra Ferraris Chiara Segré Gianluca Varetti Supported by: Francesco Blasi (SEMM PhD Program Coordinator) Deborah Agostini (web and graphic design) Sabrina Frata (SEMM events coordinator) International PhD Student Cancer Conference PARTICIPATING INSTITUTES CORE PARTICIPANTING INSTITUTES European School of Molecular Medicine (SEMM) – IFOM-IEO Campus, Milan Cancer Research UK Institutes: ▪ Beatson Institute for Cancer Research (BICR), Glasgow ▪ Cambridge Research Institute (CRI), Cambridge, UK ▪ MRC Gray Institute of Radiation Biology (GIROB), Oxford ▪ London Research Institute (LRI), London ▪ Paterson Institute for Cancer Research (PICR), Manchester The Netherlands Cancer Institute (NKI), Amsterdam INVITED INSTITUTES European Molecular Biology Labs (EMBL), Heidelberg & European Bioinformatics Institute (EMBL EBI), Hinxton German Cancer Research Centre (DKFZ), Heidelberg Medical Research Council (MRC) National Institute for Medical Research (NIMR), London National Centre for Biological Sciences (NCBS), Bangalore Spanish National Cancer Centre (CNIO), Madrid Swiss Institute for Experimental Cancer Research (ISREC-EPFL) and Department of Biochemistry of the Lausanne University (DB-UNIL), Lausanne International PhD Student Cancer Conference SPONSORS A very “Special Thanks” to our kind Sponsors International PhD Student Cancer Conference TABLE OF CONTENTS Scientific Program May 19, 2010 – Keynote lecture, lecture, oral presentations and poster session I May 20, 2010 – Lectures, poster session II and oral presentations May 21, 2010 – Keynote lecture and oral presentations Keynote Speakers Special Sessions Authors’ Index Important Addresses Know before you go - Milan International PhD Student Cancer Conference Scientific Program SCIENTIFIC PROGRAM MAY 19, 2010 h. 12.00/14.00 Registration, poster session I set up, sandwiches and hotel check in h. 14.00/14.15 Opening remarks Prof. Pier Giuseppe Pelicci (IEO, Milan) h. 14.15/14.45 Special session I Dr. Giuseppe Testa (IEO, Milan) Priming the epigenome in differentiation and cancer SESSION I: Cellular Differentiation and development Chairperson: Guillermo Menendez (LRI, London) h. 14.45/15.05 Matteo Marzi (IFOM, Milan) E1A regulated micrornas couple differentiation and cell cycle exit h. 15.05/15.25 Joerg Hoeck (LRI, London) Fbw7 controls neural stem cell differentiation and progenitor apoptosis by antagonising Notch and JNK/c-Jun signalling h. 15.25/15.45 Shefali Talwar (NCBS, Bangalore) Spatiotemporal analysis of higher order chromatin assembly during cellular differentiation h. 15.45/16.05 Feng Wang (CRI, Cambridge) The Xenopus orthologue of TGFBI is required for early embryogenesis through regulation of canonical Wnt signalling h. 16.05/16.35 Coffee break International PhD Student Cancer Conference 15 Scientific Program h. 16.35/17.45 Poster session I h. 17.45/18.30 Keynote lecture I: Dr. Peter Friedl (Nijmegen Centre for Molecular Life Sciences, Radboud University, Nijmegen; The Netherlands) Plasticity of cancer invasion and implications for therapy h. 18.30/18.45 Set up poster session II (removal posters session I) h. 18.45/21.00 “Pizza party” at the IFOM-IEO Campus bar h. 21.00 Transfer by private bus from IFOM-IEO Campus to Ripamonti apartment hotel International PhD Student Cancer Conference 16 Scientific Program MAY 20, 2010 h. 8.30 transfer by private bus from Ripamonti apartment hotel to IFOM-IEO Campus SESSION II: Cell migration & Immunology Chairperson: Meiling Gao (BICR, Glasgow) SESSION IIa: Cell migration h. 9.30-9.50 Anne Lempens (BICR, Glasgow) ERK2 but not ERK1 contributes to invasive migration of tumour cells h. 9.50-10.10 Roheet Bantval Rao (CRI, Cambridge) Huntingtin interacting protein 1 (HIP1) induces Epithelial-to-Mesenchymal Transition (EMT) in prostate cancer cells h. 10.10-10.30 Melda Tozluoglu (LRI, London) Multiscale Modelling of Cancer Cell Motility SESSION IIb: Immunology h. 10.30-10.50 Tim Schnyder (LRI, London) Spatially resolved negative regulation of B cell receptor signalling h. 10.50-11.10 Eva Schlecker (DKFZ, Heidelberg) Control of anti-tumor immune responses by myeloid-derived suppressor cells h. 11.10-11.30 Coffee break h. 11.30-12.00 Special session II: Prof. Pier Paolo Di Fiore (IFOM, Milan) Endocytosis and recycling at the crossroad of signaling, attenuation, execution of polarized functions and cell fate determination h. 12.00-12.30 Participating Institute presentations International PhD Student Cancer Conference 17 Scientific Program h. 12.30-13.30 Lunch at the IFOM-IEO Campus bar SESSION III: Modeling and large scale analysis in cancer research Chairperson: Willem-Jan Keune (PICR, Manchester) h. 13.30-13.50 Christiaan Klijn (NKI, Amsterdam) Finding co-occurrence and mutual exclusiveness of DNA copy number changes h. 13.50-14.10 Xiaofan Li (LRI, London) How does a protein find its mates in a crowded cell? h. 14.10-14.30 Gilda Nappo (IFOM, Milan) A SILAC Proteomic Approach Identified Novel Candidate Players in the Non-Clathrin Endocytic Pathway of the EGFR h. 14.30-14.50 Rebecca Burrell (LRI, London) Using Integrative Genomics To Investigate Mechanisms of Chromosomal Instability h. 14.50-16.00 Poster session II and soft drinks SESSION IV: Genome instability and cancer Chairperson: Magdalena Zajac (CNIO, Madrid) h. 16.00-16.20 Marieke Peuscher (NKI, Amsterdam) An shRNA screen to identify novel factors involved in telomere damage induced genome instability h. 16.20-16.40 Tanja van Harn (NKI, Amsterdam) Loss of RB proteins causes genomic instability in the absence of mitogenic signaling International PhD Student Cancer Conference 18 Scientific Program h. 16.40-17.00 Dhaval Varshney (BICR, Glasgow) Silent assassins: DNA methylation does not inhibit SINE transcription, but suppressed their recombination h. 17.00-17.20 Sietske Bakker (NKI, Amsterdam) Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M h. 17.20-18.05 Special session III: Bioethics round table Silvia Camporesi & Alessandro Blasimme (IFOM-IEO, Milan) World-wide human embryonic stem cell policies: who decides and on what grounds? h. 18.10 Transfer to Ripamonti apartment hotel by private bus h. 20.00 Transfer from Ripamonti apartment hotel to the Skyline Restaurant by private bus h. 20.30: Social Dinner at Skyline restaurant h 24.00 Transfer by private bus from the Skyline restaurant to Ripamonti apartment hotel International PhD Student Cancer Conference 19 Scientific Program MAY 21, 2010 h. 9.30 Transfer by private bus from Ripamonti apartment hotel to IFOM-IEO Campus SESSION V: Signal transduction & Cancer genetics and drug resistance Chairperson: Gordana Halec (DKFZ, Heidelberg) SESSION Va: Signal transduction h. 10.00-10.20 Andrea Longatti (LRI, London) Rab-GTPases and Rab-GAPs Involved in Autophagy h. 10.20-10.40 Francesca Montani (IEO, Milan) The mitotic exit oscillator at work h. 10.40-11.00 Lakshmi Revathi Perumalsamy (NCBS, Bangalore) A non-canonical Notch cascade converges on mitochondria for the regulation of cell survival SESSION Vb: Cancer genetics and drug resistance h. 11.00-11.20 Rinske Drost (NKI, Amsterdam) The impact of defined Brca1 mutations on tumor development, drug response and acquired resistance h. 11.20-11.40 Charlotte Ng (CRI, Cambridge) Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma h. 11.40-12.00 Conference photo h. 12.00-12.45 Tour of the IFOM-IEO-CAMPUS h. 12.45-13.45 Lunch at the IFOM-IEO Campus bar International PhD Student Cancer Conference 20 Scientific Program h. 13.45-14.30 Keynote lecture II : Prof. Andreas Trumpp (Divison of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and Heidelberg Institute
Load more

Recommended publications
  • Intricate SUMO-Based Control of the Homologous Recombination Machinery
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Intricate SUMO-based control of the homologous recombination machinery Nalini Dhingra and Xiaolan Zhao Molecular Biology Department, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA The homologous recombination (HR) machinery plays regulation in mammalian cells and highlight their simi- multiple roles in genome maintenance. Best studied in larities and differences with those found in yeast. It is the context of DNA double-stranded break (DSB) repair, noteworthy that SUMO plays important roles in modulat- recombination enzymes can cleave, pair, and unwind ing protein recruitment to damaged chromatin and in oth- DNA molecules, and collaborate with regulatory proteins er DNA break repair pathways. As these topics have been to execute multiple DNA processing steps before generat- well covered in other reviews (Schwertman et al. 2016; ing specific repair products. HR proteins also help to cope Garvin and Morris 2017), they are not addressed here in or- with problems arising from DNA replication, modulating der to maintain the focus on the regulation of core HR impaired replication forks or filling DNA gaps. Given machinery. these important roles, it is not surprising that each HR step is subject to complex regulation to adjust repair effi- ciency and outcomes as well as to limit toxic intermedi- Overview of the SUMO pathway and the effects ates. Recent studies have revealed intricate regulation of of sumoylation all steps of HR by the protein modifier SUMO, which SUMO, a small protein of ∼100 residues, is highly con- has been increasingly recognized for its broad influence served among eukaryotes with several isoforms found in in nuclear functions.
    [Show full text]
  • Enzymes Are Manufactured and Used by Bacteria in Order to Digest Waste
    Website: www.fermentor.co.in Food Beverages Textile Leather Agriculture Bio Pharma Effluent Treatment Enzyme : INTRODUCTION Protecting ecology is our duty. We are thus protecting our future generation. Waste water treatment has assumed great significance in today’s context where protecting the environment is a prime concern. The main objective of waste water treatment is to treat the effluent before it is discharged so that the environment is not polluted. Waste water treatment in general refers to treatment of suspended and floatable material, treatment of biodegradable organics and the elimination of pathogenic organisms. The contaminants in waste water are removed by physical chemical and biological means. These organisms are effectively removed by an enzyme called ENVIRO NZYME. ROLE OF AN ENZYME? An enzyme is a chemical catalyst that breaks up long, complex waste molecules (Hydrolytic reaction) into smaller pieces, which can then be digested directly by the bacteria. Enzymes are manufactured and used by bacteria in order to digest waste. ENVIRO NZYME – G a dry free flowing powder is a concentrated source of hydrolytic enzymes and eight strains of natural bacteria that are genetically capable of producing concentrations of enzymes in waste treatment systems under aerobic and anaerobic conditions. ENVIRO NZYME –G is used for reducing the BOD, COD levels as well as reducing the sludge volumes odour and colour in the effluent and sewage treatment plants. APPLICATION: This product finds application in industries like Agro Breweries &
    [Show full text]
  • The Role of Sumoylation of DNA Topoisomerase Iiα C-Terminal Domain in the Regulation of Mitotic Kinases In
    SUMOylation at the centromere: The role of SUMOylation of DNA topoisomerase IIα C-terminal domain in the regulation of mitotic kinases in cell cycle progression. By Makoto Michael Yoshida Submitted to the graduate degree program in the Department of Molecular Biosciences and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________________ Chairperson: Yoshiaki Azuma, Ph.D. ________________________________________ Roberto De Guzman, Ph.D. ________________________________________ Kristi Neufeld, Ph.D. _________________________________________ Berl Oakley, Ph.D. _________________________________________ Blake Peterson, Ph.D. Date Defended: July 12, 2016 The Dissertation Committee for Makoto Michael Yoshida certifies that this is the approved version of the following dissertation: SUMOylation at the centromere: The role of SUMOylation of DNA topoisomerase IIα C-terminal domain in the regulation of mitotic kinases in cell cycle progression. ________________________________________ Chairperson: Yoshiaki Azuma, Ph.D. Date approved: July 12, 2016 ii ABSTRACT In many model systems, SUMOylation is required for proper mitosis; in particular, chromosome segregation during anaphase. It was previously shown that interruption of SUMOylation through the addition of the dominant negative E2 SUMO conjugating enzyme Ubc9 in mitosis causes abnormal chromosome segregation in Xenopus laevis egg extract (XEE) cell-free assays, and DNA topoisomerase IIα (TOP2A) was identified as a substrate for SUMOylation at the mitotic centromeres. TOP2A is SUMOylated at K660 and multiple sites in the C-terminal domain (CTD). We sought to understand the role of TOP2A SUMOylation at the mitotic centromeres by identifying specific binding proteins for SUMOylated TOP2A CTD. Through affinity isolation, we have identified Haspin, a histone H3 threonine 3 (H3T3) kinase, as a SUMOylated TOP2A CTD binding protein.
    [Show full text]
  • AP Biology: Chemistry B Mcgraw Hill AP Biology 2014-15 Contents
    AP Biology: Chemistry B McGraw Hill AP Biology 2014-15 Contents 1 Carbohydrate 1 1.1 Structure .................................................. 1 1.2 Monosaccharides ............................................. 2 1.2.1 Classification of monosaccharides ................................ 2 1.2.2 Ring-straight chain isomerism .................................. 3 1.2.3 Use in living organisms ...................................... 3 1.3 Disaccharides ............................................... 3 1.4 Nutrition .................................................. 4 1.4.1 Classification ........................................... 5 1.5 Metabolism ................................................ 5 1.5.1 Catabolism ............................................ 5 1.6 Carbohydrate chemistry .......................................... 5 1.7 See also .................................................. 6 1.8 References ................................................. 6 1.9 External links ............................................... 7 2 Lipid 8 2.1 Categories of lipids ............................................ 8 2.1.1 Fatty acids ............................................. 8 2.1.2 Glycerolipids ........................................... 9 2.1.3 Glycerophospholipids ....................................... 9 2.1.4 Sphingolipids ........................................... 9 2.1.5 Sterol lipids ............................................ 10 2.1.6 Prenol lipids ............................................ 10 2.1.7 Saccharolipids ..........................................
    [Show full text]
  • Mapping of SUMO Sites and Analysis of Sumoylation Changes Induced by External Stimuli
    Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli Francis Impensa,b,c, Lilliana Radoshevicha,b,c, Pascale Cossarta,b,c,1, and David Ribeta,b,c,1 aUnité des Interactions Bactéries-Cellules, Institut Pasteur, F-75015 Paris, France; bInstitut National de la Santé et de la Recherche Médicale, Unité 604, F-75015 Paris, France; and cInstitut National de la Recherche Agronomique, Unité sous-contrat 2020, F-75015 Paris, France Contributed by Pascale Cossart, July 22, 2014 (sent for review May 28, 2014) SUMOylation is an essential ubiquitin-like modification involved in Mapping the exact lysine residue to which SUMO is attached in important biological processes in eukaryotic cells. Identification of modified proteins is a critical step to get further insight into the small ubiquitin-related modifier (SUMO)-conjugatedresiduesinpro- function of SUMOylation. Indeed, the identification of SUMO teins is critical for understanding the role of SUMOylation but remains sites allows the generation of non-SUMOylatable mutants and the experimentally challenging. We have set up a powerful and high- study of associated phenotypes. Identification of SUMO sites by throughput method combining quantitative proteomics and peptide MS is not straightforward (8). Unlike ubiquitin, which leaves immunocapture to map SUMOylation sites and have analyzed changes a small diglycine (GG) signature tag on the modified lysine resi- in SUMOylation in response to stimuli. With this technique we iden- due after trypsin digestion, SUMO leaves
    [Show full text]
  • Sumoylation Is a Post-Translational Modification Regulating Skeletal Muscle Pathophysiology
    From the Department of Physiology and Pharmacology Karolinska Institutet, Stockholm, Sweden SUMOylation is a post-translational modification regulating skeletal muscle pathophysiology Gabriel Antonio Heras Arribas Stockholm 2020 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by US-AB universitetsservice Cover: Mitochondrial distribution of GFP-tagged MuRF1 in murine myoblasts (C2C12) © Gabriel Antonio Heras Arribas, 2020 ISBN 978-91-7831-886-5 SUMOylation is a post-translational modification regulating skeletal muscle pathophysiology THESIS FOR DOCTORAL DEGREE (Ph.D.) By Gabriel Antonio Heras Arribas Principal Supervisor: Opponent: Associate Professor Stefano Gastaldello, PhD Assoc. Prof. Dorianna Sandoná Karolinska Institutet, Sweden Padova University, Italy Department of Physiology and Pharmacology Department of Biomedical Sciences Division of Pathophysiology of Striated Muscles Co-supervisor(s): Assistant professor Simone Codeluppi, PhD Examination Board: Karolinska Institutet, Sweden Prof. Nico Dantuma Department of Medical Biochemistry and Karolinska Institutet, Sweden Biophysics Department of Biomedical Sciences Dr. Nicola Cacciani Prof. Claes Andréasson Karolinska Institutet, Sweden Stockholm University, Sweden Department of Physiology and Pharmacology Department of Molecular Biosciences Division of Molecular Cell Biology Professor Lars Larsson Karolinska Institutet, Sweden Assoc. Prof. Johanna Lanner Department of Physiology and Pharmacology Karolinska Institutet, Sweden Department of Physiology and Pharmacology Division of Molecular Muscle Physiology and Pathophysiology To my wife Esther, thank you for pushing me to reach for the stars. To my parents Maria Pilar Arribas and Jose Antonio Heras, for being there every step of the way. “Do. Or do not. There is no try”. ABSTRACT The research of this thesis is focused to investigate the role of SUMOylation, a protein post-translational modification reaction, implemented to the skeletal muscle pathophysiology area.
    [Show full text]
  • Ab139470 Sumoylation Assay Kit
    ab139470 SUMOylation Assay Kit Instructions for Use For the generation and detection of SUMOylated proteins in vitro. This product is for research use only and is not intended for diagnostic use. Version 3 Last Updated 19 July 2019 1 Table of Contents 1. Background 3 2. Principle of the Assay 5 3. Protocol Summary 7 4. Materials Supplied 8 5. Storage and Stability 9 6. Materials Required, Not Supplied 10 7. Assay Protocol 11 8. Data Analysis 17 2 1. Background Small ubiquitin-related modifier (SUMO) is a member of a family of ubiquitin-like proteins that regulates cellular function of a variety of proteins. Four members of the SUMO family have been described in vertebrates: SUMO1, the close homologues SUMO2 and SUMO-3 with some 50% homology between SUMO1 and SUMO2/3 and SUMO4. Tissue-specific SUMO4, identified in human kidney, bears homology to SUMO2/3 and variants of SUMO4 may be associated with susceptibility to Type I diabetes. Although having fairly low amino acid sequence identity with ubiquitin, the SUMO enzymes exhibit similar tertiary structures. The mechanism for SUMO conjugation is analogous to that of the ubiquitin system, relying upon utilization of E1, E2 and (potentially) E3 cascade enzymes. Unlike ubiquitinylation, which leads, inter alia, to a degradative pathway, SUMO modification of target proteins is involved in nuclear protein targeting, formation of sub-nuclear complexes, regulation of transcriptional activities, and control of protein stability. For example, SUMO modification of p53 represents an additional regulator of p53 tumour repressor protein stability and may contribute to activation of the p53 response.
    [Show full text]
  • Site-Specific Characterization of Endogenous Sumoylation Across
    ARTICLE DOI: 10.1038/s41467-018-04957-4 OPEN Site-specific characterization of endogenous SUMOylation across species and organs Ivo A. Hendriks 1, David Lyon 2, Dan Su3, Niels H. Skotte1, Jeremy A. Daniel3, Lars J. Jensen2 & Michael L. Nielsen 1 Small ubiquitin-like modifiers (SUMOs) are post-translational modifications that play crucial roles in most cellular processes. While methods exist to study exogenous SUMOylation, 1234567890():,; large-scale characterization of endogenous SUMO2/3 has remained technically daunting. Here, we describe a proteomics approach facilitating system-wide and in vivo identification of lysines modified by endogenous and native SUMO2. Using a peptide-level immunoprecipi- tation enrichment strategy, we identify 14,869 endogenous SUMO2/3 sites in human cells during heat stress and proteasomal inhibition, and quantitatively map 1963 SUMO sites across eight mouse tissues. Characterization of the SUMO equilibrium highlights striking differences in SUMO metabolism between cultured cancer cells and normal tissues. Tar- geting preferences of SUMO2/3 vary across different organ types, coinciding with markedly differential SUMOylation states of all enzymes involved in the SUMO conjugation cascade. Collectively, our systemic investigation details the SUMOylation architecture across species and organs and provides a resource of endogenous SUMOylation sites on factors important in organ-specific functions. 1 Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark. 2 Disease Systems Biology Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark. 3 Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
    [Show full text]
  • Biological Sciences
    A Comprehensive Book on Environmentalism Table of Contents Chapter 1 - Introduction to Environmentalism Chapter 2 - Environmental Movement Chapter 3 - Conservation Movement Chapter 4 - Green Politics Chapter 5 - Environmental Movement in the United States Chapter 6 - Environmental Movement in New Zealand & Australia Chapter 7 - Free-Market Environmentalism Chapter 8 - Evangelical Environmentalism Chapter 9 -WT Timeline of History of Environmentalism _____________________ WORLD TECHNOLOGIES _____________________ A Comprehensive Book on Enzymes Table of Contents Chapter 1 - Introduction to Enzyme Chapter 2 - Cofactors Chapter 3 - Enzyme Kinetics Chapter 4 - Enzyme Inhibitor Chapter 5 - Enzymes Assay and Substrate WT _____________________ WORLD TECHNOLOGIES _____________________ A Comprehensive Introduction to Bioenergy Table of Contents Chapter 1 - Bioenergy Chapter 2 - Biomass Chapter 3 - Bioconversion of Biomass to Mixed Alcohol Fuels Chapter 4 - Thermal Depolymerization Chapter 5 - Wood Fuel Chapter 6 - Biomass Heating System Chapter 7 - Vegetable Oil Fuel Chapter 8 - Methanol Fuel Chapter 9 - Cellulosic Ethanol Chapter 10 - Butanol Fuel Chapter 11 - Algae Fuel Chapter 12 - Waste-to-energy and Renewable Fuels Chapter 13 WT- Food vs. Fuel _____________________ WORLD TECHNOLOGIES _____________________ A Comprehensive Introduction to Botany Table of Contents Chapter 1 - Botany Chapter 2 - History of Botany Chapter 3 - Paleobotany Chapter 4 - Flora Chapter 5 - Adventitiousness and Ampelography Chapter 6 - Chimera (Plant) and Evergreen Chapter
    [Show full text]
  • SUMO Modulation of Protein Aggregation and Degradation
    AIMS Molecular Science, 2(4): 382-410 DOI: 10.3934/molsci.2015.4.382 Received date 14 July 2015, Accepted date 30 August 2015, Published date 6 September 2015 http://www.aimspress.com/ Review SUMO modulation of protein aggregation and degradation Marco Feligioni1, *, Serena Marcelli1,2, Erin Knock3, Urooba Nadeem4 Ottavio Arancio4 and Paul E. Fraser3,5 1 Laboratory of Synaptic Plasticity, EBRI Rita Levi-Montalcini Foundation, Via del Fosso di Fiorano 64/65, Rome 00143, Italy 2 Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, 00185, Italy 3 Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, Canada 4 Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University, 630 W 168th St., New York, NY 10032, USA 5 Department of Medical Biophysics, University of Toronto, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, Canada * Correspondence: Email: m.feligioni@ebri.it; Tel: 39 06 501703112. Abstract: Small ubiquitin-like modifier (SUMO) conjugation and binding to target proteins regulate a wide variety of cellular pathways. The functional aspects of SUMOylation include changes in protein-protein interactions, intracellular trafficking as well as protein aggregation and degradation. SUMO has also been linked to specialized cellular pathways such as neuronal development and synaptic transmission. In addition, SUMOylation is associated with neurological diseases associated with abnormal protein accumulations. SUMOylation of the amyloid and tau proteins involved in Alzheimer’s disease and other tauopathies may contribute to changes in protein solubility and proteolytic processing. Similar events have been reported for α-synuclein aggregates found in Parkinson’s disease, polyglutamine disorders such as Huntington’s disease as well as protein aggregates found in amyotrophic lateral sclerosis (ALS).
    [Show full text]
  • Small-Molecule Inhibitors Targeting Protein Sumoylation As Novel Anticancer Compounds
    1521-0111/94/2/885–894$35.00 https://doi.org/10.1124/mol.118.112300 MOLECULAR PHARMACOLOGY Mol Pharmacol 94:885–894, August 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds Yanfang Yang, Zijing Xia, Xixi Wang, Xinyu Zhao, Zenghua Sheng, Yang Ye, Gu He, Liangxue Zhou, Hongxia Zhu, Ningzhi Xu, and Shufang Liang State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Downloaded from Center for Biotherapy, Chengdu (Y.Ya., Z.X., X.W., X.Z., Z.S., Y.Ye., G.H., L.Z., N.X., S.L.); Departments of Nephrology (Z.X.) and Neurosurgery (L.Z.), West China Hospital, Sichuan University, Chengdu; and Laboratory of Cell and Molecular Biology, and State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences, Beijing (H.Z., N.X.), People’sRepublicofChina Received February 26, 2018; accepted May 16, 2018 molpharm.aspetjournals.org ABSTRACT SUMOylation, one of post-translational modifications, is co- biologic functions in cancer progression, numerous small- valently modified on lysine residues of a target protein through an molecule inhibitors targeting protein SUMOylation pathway are enzymatic cascade reaction similar to protein ubiquitination. developed as potentially clinical anticancer therapeutics. Here, Along with identification of many SUMOylated proteins, protein we systematically summarize the latest progresses of associa- SUMOylation has been proven to regulate multiple biologic tions of small ubiquitin-like modifier (SUMO) enzymes with activities including transcription, cell cycle, DNA repair, and cancers and small-molecular inhibitors against human cancers innate immunity.
    [Show full text]
  • Sumoylation in Human Pathogenic Fungi: Role in Physiology and Virulence
    Journal of Fungi Review SUMOylation in Human Pathogenic Fungi: Role in Physiology and Virulence Mahima Sagar Sahu 1,2, Sandip Patra 1,2, Kundan Kumar 1,3 and Rupinder Kaur 1,* 1 Laboratory of Fungal Pathogenesis, Centre for DNA Fingerprinting and Diagnostics, Hyderabad 500039, Telangana, India; mahimasagar@cdfd.org.in (M.S.S.); sandippatra@cdfd.org.in (S.P.); kundankumar@cdfd.org.in (K.K.) 2 Graduate studies, Regional Centre for Biotechnology, Faridabad 121001, Haryana, India 3 Graduate studies, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India * Correspondence: rkaur@cdfd.org.in Received: 14 February 2020; Accepted: 3 March 2020; Published: 4 March 2020 Abstract: The small ubiquitin-related modifier (SUMO) protein is an important component of the post-translational protein modification systems in eukaryotic cells. It is known to modify hundreds of proteins involved in diverse cellular processes, ranging from nuclear pore dynamics to signal transduction pathways. Owing to its reversible nature, the SUMO-conjugation of proteins (SUMOylation) holds a prominent place among mechanisms that regulate the functions of a wide array of cellular proteins. The dysfunctional SUMOylation system has been associated with many human diseases, including neurodegenerative and autoimmune disorders. Furthermore, the non-pathogenic yeast Saccharomyces cerevisiae has served as an excellent model to advance our understanding of enzymes involved in SUMOylation and proteins modified by SUMOylation. Taking advantage of the tools and knowledge obtained from the S. cerevisiae SUMOylation system, research on fungal SUMOylation is beginning to gather pace, and new insights into the role of SUMOylation in the pathobiology of medically important fungi are emerging.
    [Show full text]